Ken Griffin Zim Vie Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$15.43 - $21.95 $408,895 - $581,675	-26,500 Reduced 86.04%	4,300 $68,000
Q2 2024 Aug 14, 2024	BUY	$14.79 - $18.47 $332,775 - $415,575	22,500 Added 271.08%	30,800 $562,000
Q1 2024 May 15, 2024	SELL	$15.92 - $20.69 $350,240 - $455,180	-22,000 Reduced 72.61%	8,300 $136,000
Q4 2023 Feb 14, 2024	BUY	$6.73 - $18.28 $32,304 - $87,744	4,800 Added 18.82%	30,300 $537,000
Q3 2023 Nov 14, 2023	SELL	$9.2 - $14.12 $13,799 - $21,180	-1,500 Reduced 5.56%	25,500 $239,000
Q2 2023 Aug 14, 2023	BUY	$7.21 - $12.14 $161,504 - $271,936	22,400 Added 486.96%	27,000 $303,000
Q1 2023 May 15, 2023	SELL	$5.31 - $11.98 $4,248 - $9,584	-800 Reduced 14.81%	4,600 $33,000
Q4 2022 Feb 14, 2023	SELL	$6.86 - $10.65 $85,132 - $132,166	-12,410 Reduced 69.68%	5,400 $50,000
Q3 2022 Nov 14, 2022	SELL	$9.37 - $19.88 $21,832 - $46,320	-2,330 Reduced 11.57%	17,810 $176,000

300

25.4M

4.3K

1.6K

Ticker ZIMV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,084,000
Market Cap $361M
Description
ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bo...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.